Cargando…
Systemic α-synuclein injection triggers selective neuronal pathology as seen in patients with Parkinson’s disease
Parkinson’s disease (PD) is an α-synucleinopathy characterized by the progressive loss of specific neuronal populations. Here, we develop a novel approach to transvascularly deliver proteins of complex quaternary structures, including α-synuclein preformed fibrils (pff). We show that a single system...
Autores principales: | Kuan, Wei-Li, Stott, Katherine, He, Xiaoling, Wood, Tobias C., Yang, Sujeong, Kwok, Jessica C. F., Hall, Katie, Zhao, Yanyan, Tietz, Ole, Aigbirhio, Franklin I., Vernon, Anthony C., Barker, Roger A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850975/ https://www.ncbi.nlm.nih.gov/pubmed/31758091 http://dx.doi.org/10.1038/s41380-019-0608-9 |
Ejemplares similares
-
Small soluble α-synuclein aggregates are the toxic species in Parkinson’s disease
por: Emin, Derya, et al.
Publicado: (2022) -
A fluorescent molecular imaging probe with selectivity for soluble tau aggregated protein
por: Zhao, Yanyan, et al.
Publicado: (2020) -
CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson’s disease
por: Li, Yuanyuan, et al.
Publicado: (2019) -
Hyperosmotic stress induces cell-dependent aggregation of α-synuclein
por: Fragniere, Alexandra M. C., et al.
Publicado: (2019) -
α-Synuclein and Anti-α-Synuclein Antibodies in Parkinson’s Disease, Atypical Parkinson Syndromes, REM Sleep Behavior Disorder, and Healthy Controls
por: Smith, Lynnae M., et al.
Publicado: (2012)